drug discovery
Oxford BioTherapeutics, Boehringer Ingelheim Extend Drug Discovery Collaboration
The firms have previously advanced two programs identified by Oxford's platform into Phase I clinical development.
Lupus Research Alliance Launches Landmark Study to Speed Personalized Drug Development
Investigators aim to enroll 3,500 patients into the prospective, observational study, which is supported by multiple drugmakers.
MultiOmic Health Raises £5M in Seed Funding Extension Round
The UK precision therapeutics discovery startup will use the new funding for a proof of concept in diabetic kidney disease.
M2Gen, Absci Team to Accelerate Precision Oncology Drug Discovery With AI
Drug development firm Absci will use M2Gen's ORIEN Avatar clinical and molecular dataset to match antigens to antibodies in pursuit of novel cancer biologics.
Rezo Therapeutics Launches With $78M in Series A Funding
The firm will initially focus on developing a pipeline of biomarker-guides therapies for solid tumors.
Jun 11, 2020
Seven Bridges Building Research Platform for PanCAN
May 1, 2019